The below are the clinical trials posted for the first time in April 2024.

Phase 4:

  1. Clinical Outcome and Biomarkers for Predicting Immunological Response in Patients Treated With Imiquimod
  2. Cancer-related Fatigue in Patients With Breast Cancer Treatment With Zhengyuan Capsules
  3. A National Multicenter, Real-world Study of Linperlisib in the Treatment of Lymphoma
  4. Serplulimab Combined With Nab-paclitaxel and Cisplatin in Neoadjuvant Therapy for Resectable Esophageal Squamous Cell Carcinoma
  5. The Study of Huaier Granule in Postoperative Adjuvant Therapy of Resectable Pancreatic Cancer
  6. Sphenopalatine Ganglion Block for Postop Pain Management
  7. Examining the Effect of Different Filling Techniques on Healing in Lesional Teeth
  8. Clinical Study of Huaier Granule in the Treatment of Unresectable Pancreatic Cancer
  9. Blinatumomab for Relapsed Acute B Lymphoblastic Leukemia After Transplantation
  10. A Single-arm Pilot Study of Tislelizumab Combined With Anlotinib in Patients With Advanced NSCLC With Driver-negative After Progression to Immunotherapy
  11. Oral Azacitidine in Transplant-Eligible Patients With Acute Myeloid Leukemia (AML) Suffering From Health-Inequality
  12. A Phase 4, Multi-center, Open Label Trial to Evaluate Efficacy of Retreatment With Nadofaragene Firadenovec in Subjects With CIS Β± High-grade Ta/T1 and no Complete Response to First Nadofaragene Firadenovec Dose
  13. Preoperative Neoadjuvant Immunotherapy Combined With Chemotherapy for Stage β…Ά Unresectable Non-small Cell Lung Cancer
  14. Feasibility of Intraoperative Tracing of Meningioma Using [Cu64]DOTATATE

Phase 3:

  1. A Pivotal Phase 3 Study of APG-2575 (Lisaftoclax) Combined With Azacytidine in the Treatment of Acute Myeloid Leukemia
  2. An Phase III Study, Multicenter,Randomized Controlled Trail to Determine the Safety and Efficacy of the Combination of Tislelizumab With Cisplatin and Gemcitabine, With or Without Trilaciclib for Patients With Untreated Unresectable and Metastatic Urothelial Carcinoma.
  3. Immediate Corticosteroid Therapy and Rituximab to Prevent Generalization in Ocular Myasthenia: a PROBE Multicenter Open-label Randomized Controlled Trial.
  4. Liquid Biopsy (ctDNA) Guided Treatment in Localized Pancreatic Cancer: Neoadjuvant CTX vs. Upfront Surgery
  5. A Phase III Study of ESG401 for Locally Advanced or Metastatic HR+/HER2- Breast Cancer
  6. A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2)
  7. A Global Phase 3 Study of Orelabrutinib+BR vs.BR in Pts With TN MCL
  8. AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2
  9. CARE1 Pragmatic Clinical Trial
  10. A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)
  11. A Study of AK104+Lenvatinib in Combination With Transarterial Chemoembolization (TACE) Versus TACE in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma
  12. Study to Compare the Effectiveness and Safety of Golcadomide Plus R-CHOP vs Placebo Plus R-CHOP in Participants With Previously Untreated High-risk Large B-cell Lymphoma
  13. A Study Comparing BL-B01D1 With Docetaxel in Patients With Unresectable Locally Advanced or Metastatic EGFR Wild-type Non-small Cell Lung Cancer
  14. Cytoreductive Prostatectomy Combined With Triple or Dual Systemic Therapy in mHSPC Patients
  15. A Study of AK104/Placebo Plus AK109/Placebo And Paclitaxel in Gastric or Gastroesophageal Junction Adenocarcinoma
  16. A Study of Efgartigimod PH20 SC in Children Between 2 and Less Than 18 Years of Age With Generalized Myasthenia Gravis
  17. Tislelizumab in Combination With GP or TPC Regimen for the Treatment of Nasopharyngeal Carcinoma With Bone Metastasis.
  18. A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Unresectable Locally Advanced, Recurrent, or Metastatic HR+HER2- Breast Cancer
  19. Glucose Control Through a Bihormonal Artificial Pancreas in Patients After Total Pancreatectomy
  20. Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/6i.
  21. MA+AZA Regimen for the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)
  22. JMT101 in Combination With Osimertinib, Versus Cisplatin-pemetrexed in Participants With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Characterized by Epithermal Growth Factor Receptor (EGFR) Exon 20ins Mutations
  23. LM-302 for the Treatment of Subjects With Claudin18.2-Positive Gastric and Gastroesophageal Junction Adenocarcinoma.
  24. A Study of MK-1084 Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant, Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004)
  25. A Study to Evaluate HMPL-306 in Patients With IDH1- and IDH2-mutated Acute Myeloid Leukemia
  26. An Organ Preservation Strategies After Chemoradiotherapy Combined With Immunotherapy for Esophageal Cancer (PALACE3).
  27. A Study to Compare the Efficacy, Safety, Pharmacokinetics, and Immunogenicity Between SB27 and Keytruda in Subjects With Metastatic Non-squamous Non-small Cell Lung Cancer
  28. Chemotherapy Omission in ER+/HER2- Breast Cancer With 1-3 Positive Lymph Nodes Receiving Extended Adjuvant Abemaciclib
  29. Spinal Morphine or Intravenous Lidocaine in Robot-assisted Upper Urologic Surgery
  30. A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer
  31. Ultra-high Dose Radiation for Liver Metastasis Using MR-guided TReatment With Stereotactic Ablative Single-fraction
  32. A Study Comparing BL-B01D1 With Platinum Based Chemotherapy in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer
  33. Haplo-cord HCT vs. Haplo-HCT for T-ALL Patients
  34. Estradiol and Testosterone Subdermal Implants for Menopause Treatment (ESTIME)
  35. The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
  36. Stereotactic Body Radiotherapy vs Conventional Palliative Radiotherapy for Painful Bone Metastases
  37. A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer
  38. Nimotuzumab Combined With Trifluridine/Tipiracil in the Treatment of Refractory Metastatic Colorectal Cancer
  39. A Study Comparing Niraparib With Temozolomide in Adult Participants With Newly-diagnosed, MGMT Unmethylated Glioblastoma
  40. Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
  41. Saruparib (AZD5305) Plus Camizestrant Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer
  42. Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
  43. Combination of Immune Checkpoint in Locally Advanced or Metastatic MSI/dMMR Esogastric Adenocarcinomas
  44. Brightline-3: A Study to Find Out Whether Brigimadlin in Combination With Ezabenlimab Helps People With Advanced Soft Tissue Sarcoma
  45. A Study to Evaluate Sacituzumab Tirumotecan (MK-2870) in Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-2870-015)
  46. A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.

Phase 2-3:

  1. Maintenance Hormonal Therapy and DLBCL
  2. The Effect of [18F] F-FAPI PET-CT on Management in Patients With Proximal Cholangiocarcinoma
  3. ICP-248 in Combination With Orelabrutinib in Treatment-naΓ―ve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
  4. GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Cancer Patients
  5. A Phase II/III Trial to Evaluate the Efficacy and Safety of Surufatinib Combined With Camrelizumab, Nab-paclitaxel, and Gemcitabine in Metastatic Pancreatic Cancer
  6. A Study of Neoadjuvant Therapy for the Treatment of Patients With Locally Advanced Esophageal Squamous Cell Carcinoma
  7. Application of MRD Combined With Personalized Vaccine in the Treatment of Postoperative Recurrence Prevention of EOC

Phase 2:

  1. To Evaluate the Efficacy and Safety of Disitamab Vedotin Combined With Toripalimab Sequential Chemotherapy as Neoadjuvant Treatment in Patients With HR-positive, HER2-low Breast Cancer
  2. A Prospective Study of Whole-Brain RT Combined With Thiotepa Sheath Injection Combined With Systemic Therapy for the Primary Disease in the Treatment of Meningeal Metastases in Solid Tumors
  3. Risk Stratified De-escalated Hormone Therapy With Radiation Therapy for the Treatment Prostate Cancer
  4. Effects of Maintenance Cabozantinib+BSC Versus BSC in Children and AYA With Osteosarcoma
  5. Tislelizumab Combined With Neoadjuvant Chemotherapy Used in the Perioperative Treatment.
  6. PRORAD-5 PROstate RADiation in 5 Fractions: Phase Ib Five Fraction Radiotherapy for Patients With Advanced Prostate Cancer
  7. Stereotactic Body Proton Therapy for Treatment of Primary Renal Cell Carcinoma
  8. Babytam vs Babyexe in Post-menopausal Women at High Risk for Breast Cancer.
  9. Efficacy and Safety of Concurrent PD-1 Inhibitor and Radiotherapy With Immunonutrition for Esophageal Squamous Cell Carcinoma
  10. Status of HRD That Lead to a Benefit From Olaparib in Combination With Bevacizumab (STROBE Trial)
  11. A Study to Evaluate the Combination of Platinum-pemetrexed Based Chemotherapy Plus Lorlatinib in ALK Positive Non-Small Cell Lung Cancer (NSCLC) With Exclusively Extracranial Disease Progression on Lorlatinib
  12. A Study of Phase2, IMC-001 In Patients With Metastatic Or Locally Advanced TMB-H Solid Tumor
  13. Molecular Analyses to Identify Pathways of Endocrine Resistance Following Short Term Neoadjuvant Endocrine Treatment in Patients With Hormone Receptor-Positive HER2-negative Breast Cancer
  14. A Phase II Study of SHR2554 in Patients With Relapsed or Refractory Follicular Lymphoma
  15. MT2022-60: Ph 2 Study of Pembro+ BEAM With ASCT for Relapsed Hodgkin Lymphoma
  16. PPIO-008S-1 Combined With Tislelizumab in Patients With Primary Residual Node-negative Esophageal Squamous Cell Carcinoma (ESCC) After Radical Resection With Neoadjuvant Immunotherapy Combined With Chemotherapy, PHASE II STUDY
  17. Single-arm Study of Nimotuzumab Combined With mFOLFIRNIOX as Postoperative Adjuvant Therapy in Pancreatic Cancer
  18. Study Evaluating the Efficacy of the myDIET Software Tool in the Nutritional Management of Patients With Localized and Resectable Gastric or Esogastric Junction Cancer.
  19. Study of the Rechallenge Concept in Patients With BRAF-positive Anaplastic Thyroid Cancer After Progression on Anti-BRAF Therapy
  20. Intratumoral INT230-6 Followed by Neoadjuvant Immuno-chemotherapy in Patients With Early TNBC. INVINCIBLE-4-SAKK
  21. Sunvozertinib Plus Anlotinib as 1L Treatment in EGFR-Sensitive Mutations Combined With Co-Mutations Advanced NSCLC
  22. Clinical Study on the Prevention and Treatment of Postoperative Metastasis of Lung Cancer by Fuzheng Quxie Recipe
  23. TTField in Combination With TMZ and Tislelizumab in The Treatment of Newly Diagnosed Glioblastoma.
  24. JMT101 Combined With Osimertinib in Patients With Stage β…Άb-β…£ Non-small Cell Lung Cancer (NSCLC) Characterized by Epithermal Growth Factor Receptor (EGFR) Common Mutations
  25. Adebrelimab and Chemoradiotherapy in High-risk Locoregionally Advanced Nasopharyngeal Carcinoma
  26. A Study of Anti-CD19 CAR T-Cell Therapy, in Subjects With Refractory Primary and Secondary Progressive Multiple Sclerosis
  27. A Phase II Study of SSGJ-707 Monotherapy in First-line PD-L1 Positive Advanced NSCLC Patients
  28. Efficacy and Safety of Dalpiciclib With Endocrine Therapy as Adjuvant Treatment in HR+/ HER2- Early Breast Cancer
  29. Sintilimab Combination Therapy Plus IMRT in Nasopharyngeal Carcinoma
  30. IMMUNOPLANT for Newly Diagnosed Multiple Myeloma
  31. Testing Sunitinib as Potentially Targeted Treatment in Cancers With cKIT Genetic Changes (MATCH - Subprotocol V)
  32. DEB-TACE Prior to Liver Transplantation in the Treatment of HCC
  33. A Study of BV-AVD in People With Bulky Hodgkin Lymphoma
  34. TOP 2301: Neoadjuvant Chemo for NSCLC
  35. Testing the Addition of Radiation Therapy to the Immune Therapy Treatment for ES-SCLC
  36. A Study of HB-202/HB-201 in People With Human Papilloma Virus 16-Positive Head and Neck Squamous Cell Cancer (HPV 16+ HNSCC)
  37. A Study to Explore the Reasonable Dosage and Evaluate the Efficacy, Safety and Tolerability of HLX10 and HLX04 With or Without HLX53 in Untreated, Locally Advanced or Metastatic Hepatocellular Carcinoma Patients.
  38. The Clinical Effectiveness and Safety of Intravesical Mitomycin-C and Gemcitabine Sequential Therapy
  39. A Study of TAE+HAIC Combined With Camrelizumab and Apatinib in the Treatment of Advanced Hepatocellular Carcinoma
  40. Phase II Study of Moderate-dose Hypofractionated RT Combined With Pembrolizumab for HCC With Diffuse Tumor Thrombosis
  41. Testing Palbociclib (PD-0332991) as Potentially Targeting Treatment in Cancers With CDK4 or CDK6 Amplification (MATCH - Subprotocol Z1C)
  42. Hyperpolarized (HP) 13C Pyruvate Magnetic Resonance Imaging (MRI) MRI as a Response Monitoring Tool to Neoadjuvant Abiraterone
  43. Clinical Study of CAR-T Cell Therapy Following ASCT for R/R B-cell Non-Hodgkin's Lymphoma
  44. First-line Treatment for Unresectable Locally Advanced Distal Cholangiocarcinoma Combining Radiotherapy and HAIC
  45. Second-line Treatment With CAdonilimab and LEnvatinib for Unresectable HCC
  46. Remote Cognitive Assessment Battery and Wearable Device Monitoring Platform While Assessing the Impact of Metformin in Patients With History of Cranial Radiation Therapy
  47. Testing MLN0128 (TAK-228) as Potentially Targeted Treatment in Cancers With mTOR Genetic Changes (MATCH - Subprotocol L)
  48. Minimal Residual Disease-based Strategy With T-Cell Redirector After Treatment With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone (D-VRd) in Newly Diagnosed Multiple Myeloma
  49. Phase II Study of Irinotecan Liposomes in First-line Treatment of Metastatic Colorectal Cancer
  50. A Multicenter, Prospective Study of Diarrhea Tolerance of Pyrotinib Combined With Trastumab and Taxane in the First-line Treatment of HER2-positive Advanced Breast Cancer
  51. Ivonescimab Combined With HAIC for the Treatment of Unresectable Hepatocellular Carcinoma(uHCC).
  52. Serplulimab Combined With Bevacizumab Biosimilar and HAIC in Advanced Hepatocellular Carcinoma (HCC) Patients
  53. Organ Preservation With Tislelizumab and Total Neoadjuvant Therapy in Patients With Low Rectal Cancer: RELIEVE -01 Study
  54. Durvalumab Combined With Chemoradiotherapy for Limited Stage Small Cell Lung Cancer (Camel-01)
  55. HER2 Targeted Molecular Imaging in mBC Using 68Ga-ABS011
  56. ICI Rechallenge for Advanced NSCLC With Long-Term Response to First-Line ICI
  57. RC48 Combined With Adebrelimab, Apatinib and S-1 as Neoadjuvant Therapy in Locally Advanced Gastric Cancer
  58. DV Combined With Toripalimab for Renal Preservation in Solitary Kidney or Renal Insufficiency or Bilateral Multiple UTUC
  59. Siltuximab for Cytokine Release Syndrome Prophylaxis Prior to tx w/ Teclistamab in RRMM
  60. MRD Guided Sonrotoclax and Zanubrutinib in Newly Diagnosed CLL/SLL
  61. Stereotactic Body Radiation Therapy Plus Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy for Treatment of Metastatic, Recurrent Hormone-Sensitive Prostate Cancer, DIVINE Trial
  62. Study of Cemiplimab Alone or in Combination With Fianlimab and/or Other Experimental Agents in Adult Participants With Peri-operative Stage III/IV Cutaneous Squamous Cell Carcinoma (CSCC)
  63. Bortezomib, Pomalidomide, Dexamethasone For Systemic AL Amyloidosis
  64. Testing MLN0128 (TAK-228) as Potentially Targeted Treatment in Cancers With TSC1 or TSC2 Genetic Changes (MATCH - Subprotocol M)
  65. Surufatinib Combined With Gemcitabine Plus Nab-paclitaxel in Locally Advanced Pancreatic Cancer
  66. SHR-A1811 Alone or in Combination With Adebrelimab as Neoadjuvant Treatment in ER Positive/HER2 Low Breast Cancer
  67. An Acupuncture Study for People At High Risk for Sepsis
  68. Neo-Sequence 2:NCT Plus Anti-angiogenesis Therapy and Immunotherapy for LADGC
  69. Nab-paclitaxel Combined With Cadonilimab (AK104) for the Second-line Treatment of Advanced Gastric Cancer
  70. A Multicenter Clinical Study of Apatinib Mesylate Combined With Doctor's Choice for Advanced Breast Cancer
  71. Immunosensitized Radiotherapy Combined With Evoximab (AK112) and Chemotherapy Neoadjuvant Therapy for Stage II-III Non-small Cell Lung Cancer
  72. To Evaluate the Safety and Tolerability of Carbognilumab Combined With Chemotherapy as the First-line Treatment for Patients With KEAP1 Mutated Advanced or Postoperative Recurrent Non-small Cell Lung Cancer (NSCLC)
  73. Maintenance Therapy of Hypomethylating Agent (HMA) in Favorable Risk Acute Myeloid Leukemia (AML) Patients
  74. DEC-C and Thioguanine for R/R AML
  75. Utidelone (UTD1) Plus Capecitabine in Non-pCR TNBC After Neoadjuvant Therapy
  76. Cessation of Somatostatin Analogues After PRRT in Mid-Gut Neuroendocrine Tumours
  77. Radical Concurrent Chemoradiotherapy With DDP/5-FU and PD-1 Antibody for Non-metastatic Rectal Squamous Cell Carcinoma
  78. SHR-A1811 Combined With Bevacizumab in HER2-positive Breast Cancer With Brain Metastases
  79. Patritumab Deruxtecan in Patients With Solid Tumor Harboring an NRG1 Fusion
  80. Sintilimab Combined With Fruquintinib/Regorafenib Β± Radiotherapy for Third-line Treatment of Advanced Metastatic Colorectal Cancer
  81. Efficacy of Pembrolizumab and Lenvatinib in Patients With Anaplastic Thyroid Cancer
  82. Neo-adjuvant Chemo and Immunotherapy in The Pre-operAtive Treatment of Locally Advanced cholangIOcarciNoma
  83. Adjuvant Rezvilutamide in Combination With Androgen Deprivation Therapy in Androgen Receptor-positive, High-risk Salivary Duct Carcinoma
  84. Efficacy and Safety of Low-dose Chemotherapy Plus Immuno-targeted Drugs in Newly Diagnosed Elderly/Unfit Ph- B-ALL
  85. PSMA-Directed Para-Aortic Radiation Therapy for Oligorecurrent Prostate Cancer
  86. Study of Neoadjuvant Enfortumab Vedotin and Pembrolizumab in Cisplatin-eligible Upper Tract Urothelial Cancer
  87. A Study to Evaluate the Efficacy and Safety in Subjects With Advanced Breast Cancer Treated With SYHX2011
  88. A Study of Treatment-free Remission in Chronic Phase Chronic Myeloid Leukemia
  89. Clinical Trial of ssCART-19 Cell Injection in the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia (Including Central Nervous System Infiltration)
  90. Concurrent Chemoradiotherapy Combined With Sintilimab as Neoadjuvant Therapy for GC Patients With PALM
  91. Irinotecan Liposome II in Combination With 5-FU/LV and Oxaliplatin in Perioperative Treatment of Borderline Resectable Pancreatic Cancer
  92. Efficacy of N-acetylcysteine in Preventing Radiotherapy-Induced Oral Mucositis in Head and Neck Cancer Patients.
  93. Azenosertib in Uterine Serous Carcinoma: Biomarker Study
  94. Nocardia Rubra Cell Wall Skeleton in Combination With Prior Second- or Third-line Regimens for the Treatment of Potentially Hazardous Colorectal Cancer SD Status
  95. Sintilimab Plus FOLFIRI as Salvage Therapy for Patients With Advanced Gastric Cancer
  96. Ropidoxuridine as a Radiosensitizer in Newly Diagnosed IDH-Wildtype Glioblastoma With Unmethylated MGMT Promoter
  97. GU-01: Glycyrrhizin in Prostate Cancer
  98. A Randomized Phase II Basket Trial EXTENDing Efficacy of Systemic Therapy With Local Consolidative Therapy for OligoProgressive Metastatic Disease (EXTEND-OP)
  99. To Evaluate the Efficacy and Safety of Anrotinib Hydrochloride Capsule in Postoperative Non-pCR Patients With Non-small Cell Lung Cancer
  100. Prophylactic Administration of Neulapeg (Pegteograstim) in Patients With Locally Advanced or Metastatic Pancreatic Cancer Receiving the Modified FOLFIRINOX
  101. Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advance or Metastatic Pancreatic Cancer
  102. Radiation Therapy Followed by Tislelizumab and Anlotinib Aeoadjuvant/Adjuvant Therapy for Stage II-IIIA NSCLC
  103. Response Adaptive Radiotherapy Following Immunotherapy-based Induction for Non-HPV Related HNSCC
  104. CAR-T Following ASCT for Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (R/R B-NHL) With High-Risk Prognostic Factors
  105. Rituximab and Zanubrutinib in Patients With Indolent B-cell Lymphomas
  106. Osimertinib Plus Dalpiciclib in Patients With EGFR-mutant, CDK4/6 Pathway Aberrant, Advanced Non-small Cell Lung Cancer Following Acquired Resistance to Third-generation EGFR TKI: a Phase II Trial
  107. Neoadjuvant IMRT Combined With Camrelizumab and Apatinib for Resectable HCC With PVTT
  108. Magnetic Resonance (MR) Imaging With Hyperpolarized 13C-Pyruvate +/- 13C,15N-Urea in Patients With Prostate Cancer
  109. Niraparib, Abiraterone Acetate and Prednisone for mHSPC With Deleterious Homologous Recombination Repair Alterations
  110. Combination Immunotherapy of Adebrelimab With Apatinib and Tegafur for Immune Rechallenge Therapy in Esophageal Squamous Cell Carcinoma
  111. Neoadjuvant Ipilimumab/Nivolumab for Patients With Recurrent, High Risk, Resectable Melanoma
  112. Assessing the Efficacy and Safety of Anti-HER2 Therapy in Nigerian Women With HER2+ Breast Cancer Before and After Surgery
  113. DISCERN: Dual Versus Single ICB in PDL-1 Negative NSCLC
  114. Fluorouracil Treatment Via Colon for Colorectal Cancer
  115. Serplulimab Combined With Concurrent Chemoradiotherapy for Locally Advanced Treatment Esophageal Cancer in Old Age
  116. Chemotherapy Followed by Response-Based Reduced Radiation Therapy for Patients With Central Nervous System Germinomas
  117. HAIC Combined With PD-L1 Plus Regorafenib in the Treatment of Advanced Hepatocellular Carcinoma After Immunotherapy Failure
  118. Toripalimab With or Without Lenvatinib or Chemotherapy in First-Line Treatment of Advanced Biliary Tract Cancer
  119. Atezolizumab and Bevacizumab With Photon Radiotherapy for Unresectable Hepatocellular Carcinoma
  120. Inosine Reverse Chemo Resistance in Triple Negative Breast Cancer
  121. Neoadjuvant Chemotherapy Plus Sequential Immune Checkpoint Inhibitor (ICI) Therapy in Locally Advanced Colon Cancer
  122. Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)
  123. Tailoring Therapy in Post-surgical Patients With Low-risk Endometrial Cancer
  124. Carboplatin/Paclitaxel + Pembrolizumab for Locoregionally Advanced Penile Cancer
  125. PD-1 Combined With Chemotherapy and PULSAR in LAPC and Local Recurrence Patients
  126. The Application of Pressured Intraperitoneal Aerosol Chemotherapy (PIPAC) for Peritoneal Surface Malignancies
  127. Testing Crizotinib as Potentially Targeted Treatment in Cancers With MET Genetic Changes (MATCH - Subprotocol C1)
  128. Open-label Phase 2 Study of Avutometinib (RAF/MEK Clamp) in Combination With Defactinib (FAK Inhibitor) and Cetuximab in Patients With Unresectable, Anti-EGFR-Refractory Advanced Colorectal Cancer
  129. Testing Crizotinib as Potentially Targeted Treatment in Cancers With MET Exon 14 Deletion Genetic Changes (MATCH - Subprotocol C2)
  130. NOvel Immunotherapy Strategies for Advanced Triple Negative Breast Cancer (TNBC) Patients: TONIC-3 Trial
  131. HAIC+Adebrelimab+Lenvatinib for Conversion Treatment of Potentially Resectable, Locally Advanced Biliary Tract Cancer
  132. A Study of SC-0191 in Subjects With Metastatic Colorectal Cancer
  133. A Single Arm, Single Centered Phase II Trial on the Combination of Adebrelimab, Surufatinib and Irinotecan Liposome-based HAIC in Advanced iCC
  134. Anti-PD-1/PD-L1 Combined With Anti-angiogenic Agents as First-line Treatment for Unresectable HCC
  135. A Clinical Study of Adebrelimab Combined With Apatinib and Paclitaxel in Patients With Advanced Gastric Cancer.
  136. the Prevention of Bone Marrow Suppression Caused by Chemotherapy in Advanced NSCLC With Trilaciclib
  137. NALIRIFOX in Combination With Camrelizumab for BRPC: a Prospective, Exploratory Study
  138. To Assess the Safety and Efficacy of SP-002 With Vismodegib for the Treatment of Locally Advanced Basal Cell Carcinoma
  139. Cadonilimab Combined With Chemotherapy as First or Second Line Treatment in Recurrent or Metastatic Triple Negative Breast Cancer
  140. Efficacy and Toxicity of Docetaxel as a Radiosenstizer in Head and Neck Cancer
  141. Testing GDC-0449 (Vismodegib) as Potentially Targeted Treatment in Cancers With Smoothened or Patched 1 Mutant Tumors (MATCH - Subprotocol T)
  142. Nilatinib Maleate Tablets Combined With Capecitabine in the Treatment of HER2-positive Advanced Esophageal/Esophagogastric Junction/Gastric Adenocarcinoma With Brain Metastases
  143. HR070803 in Combination With Oxaliplatin, S-1 Versus NALIRIFOX as Adjuvant Therapy for Pancreatic Cancer
  144. A Clinical Study on the Efficacy and Safety of Paclitaxel Polymer Micelles and Cisplatin Combined With Cadonilimab as a Neoadjuvant Therapy for Locally Advanced Esophageal Squamous Cell Carcinoma
  145. Testing Copanlisib as Potentially Targeting Treatment in Cancers With PTEN Loss (MATCH - Subprotocol Z1G)
  146. Bicalutamide and Abemaciclib in Inoperable or Metastatic Androgen Receptor-positive Triple-negative Breast Cancer
  147. A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
  148. Neoadjuvant PD-1 Blockade for Elderly Esophageal Squamous Cell Carcinoma (BLESS)
  149. Anlotinib Combined With Penpulimab as Front-line Treatment in Advanced Non-small Cell Lung Cancer
  150. Tislelizumab With Fruquintinib, Metronidazole, in Mismatch Repair-proficient or Microsatellite Stability, Advanced Colorectal Cancer: a Multicenter, Single Arm, Clinical Trial
  151. Intraarterial Carboplatin + Caelyx Compared to Intraarterial Carboplatin + Etoposide Phosphate for Progressing Glioblastoma
  152. Neoadjuvant INBRX-106 (Hexavalent OX40 Agonist) in Combination With Pembrolizumab as a Chemotherapy-sparing Regimen for Stage II TNBC (Triple Negative Breast Cancer) Patients
  153. Intestinal Microbiota Transplant Prior to Allogeneic Stem Cell Transplant (MAST) Trial
  154. Disitamab Vedotin Plus Cadonilimab in Patients With HER2 Mutant Advanced or Metastatic Bile Duct Adenocarcinoma
  155. Pirtobrutinib With Rituximab for the Treatment of Newly Diagnosed Marginal Zone Lymphoma
  156. Trial for Treatment of High Risk BC With Two Sequences of Neoadjuvant Chemotherapy With Pembrolizumab
  157. Genomic Biomarker-guided Neoadjuvant Therapy for Prostate Cancer (SEGNO)
  158. HAIC Combined With Durvalumab and Tremelimumab and Lenvatinib in uHCC
  159. Sunvozertinib Plus Anlotinib as 1L Treatment in EGFR Mutant Advanced NSCLC-RW
  160. Testing LOXO-101 as Potentially Targeted Treatment in Cancers With NTRK Genetic Changes (MATCH - Subprotocol Z1E)
  161. Niraparib and Dostarlimab for Patients With MMR-D/MSI-H Colorectal Cancers
  162. Potential Protective Role of SGLT-2 Inhibitors for Chemotherapy-induced Cardiotoxicity
  163. A Study of Furmonertinib Combined With Chemotherapy in the Treatment of NSCLC With Leptomeningeal Metastasis
  164. A Trial of Cadonilimab With Adriamycin in Patients With Advanced Soft Tissue Sarcoma
  165. Precision Medicine in Patients With Unresectable CholAngiocarcinoma: RadioEmbolization and Combined Biological Therapy
  166. Reduced Dose Radiotherapy for the Treatment of Indolent Non-Hodgkin Lymphoma
  167. Dasatinib Combined With Quercetin to Reverse Chemo Resistance in Triple Negative Breast Cancer
  168. Efficacy and Safety of Ribociclib in Combination With NSAI Versus Physician's Choice of Chemotherapy Sequential Endocrine Therapy in HR+/HER2- Advanced Breast Cancer
  169. De-Escalation Postoperative Radiotherapy for Oral Squamous Cell Carcinoma With pCR/MPR.
  170. PD-L1/PD-1 Inhibitors Plus Chemotherapy Versus Chemotherapy Alone for the Neoadjuvant Treatment of Limited-stage SCLC
  171. A Multicenter, Prospective, Phase II Study of Zanubrutinib for Maintenance in Patients With Mantle Cell Lymphoma
  172. A Phase 2, Open Label Study of PEmigatinib and REtifanlimab in Advanced Dedifferentiated LIposarcoma (PERELI)
  173. Namodenoson Treatment of Advanced Pancreatic Cancer
  174. Safety and Efficacy of XELOX Combined With Sintilimab and Lenvatinib in Advanced AFP-positive Gastric Cancer Patients
  175. EF-39 PANOVA-4: Study of Tumor Treating Fields Concomitant With Atezolizumab, Gemcitabine and Nab-Paclitaxel as First-LineTreatment for Metastatic Pancreatic Ductal Adenocarcinoma
  176. Testing JNJ-42756493 (Erdafitinib) as Potentially Targeting Treatment in Cancers With FGFR Mutations or Fusions (MATCH - Subprotocol K2)
  177. A Study Comparing Venetoclax and Azacitidine Plus Cusatuzumab to Venetoclax and Azacitidine in Newly Diagnosed AML Ineligible for Intensive Therapy
  178. LM-108 in Combination With PD-1 Based Treatment for Patients With Recurrent or Metastatic Triple - Negative Breast Cancer
  179. PCSK9 Inhibitors in Combination With Advanced Treatment Strategies for the Treatment of Advanced Colorectal Cancer With pMMR/MSS
  180. ALPINE: Maintenance Letrozole/Abemaciclib vs Pembrolizumab
  181. Study of ST-1898 in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Cancer
  182. To Assess The Patient Preference for Goserelin Microsphere Versus Goserelin Implant in Patients With Prostate Cancer
  183. Tirelizumab in Combination With Carboplatin and Polymeric Micellar Paclitaxel for Neoadjuvant Therapy in cN+ HNSCC
  184. Dara-RVd Induction for Newly Diagnosed Multiple Myeloma With Autologous Stem Cell Transplantation
  185. Testing Afatinib as Potentially Targeted Treatment in Cancers With EGFR Genetic Changes (MATCH - Subprotocol A)
  186. A Study of 2141-V11 in Combination With Standard Treatments in People With Prostate Cancer
  187. A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma
  188. Study of Suratadenoturev (OBP-301) in Combination With Pembrolizumab in Esophagogastric Adenocarcinoma
  189. Neoadjuvant Targeted Therapy in Patients With Resectable EGFR-mutated Lung Squamous Cell Carcinoma
  190. Chemoradiotherapy With or Without Metformin in Locally Advanced Cervical Cancer
  191. A Study of Ocular Toxicity Evaluation and Mitigation During Treatment With Mirvetuximab Soravtansine in Participants With Recurrent Ovarian Cancer With High Folate Receptor-Alpha Expression
  192. Linperlisib-based Treatment Regimen in Newly Diagnosed Nodal T-follicular Helper Cell Lymphoma (nTFHL)
  193. Intratumoral and Systemic HiltonolΒ® (Poly-ICLC) in Prostate Cancer Patients on Active Surveillance
  194. Topical Tretinoin Prophylaxis for Anti-EGFR Induced Skin Toxicity in Metastatic Colorectal Cancer
  195. A Study of LVGN6051 Combination Therapy in Patient With Head and Neck Squamous Cell Carcinoma (HNSCC)

Phase 1-2:

  1. Trifluridine/Tipiracil Combined With Cetuximab in the Treatment of Third-line and Above RAS/BRAF Wild-type mCRC
  2. Phase I/II Study of DFP-10917 in Combination With Venetoclax in Relapsed or Refractory Acute Myeloid Leukemia
  3. ON 123300 (Narazaciclib) and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma
  4. A Study of ST-1898 for Unresectable or Metastatic Melanoma
  5. Neoadjuvant Triple Treatment for Borderline Resectable Pancreatic Cancer (PREOPANC-5)
  6. Glofitamab Plus Ibrutinib With Obinutuzumab for the Treatment of Patients With Mantle Cell Lymphoma
  7. A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Recurrent/Metastatic Head and Neck Cancer
  8. A Study of AK117 in Combination With Azactidine Plus Venetoclax in Patients With Acute Myeloid Leukemia
  9. Study of ZG005 in Combination With Etoposide and Cisplatin in Participants With Advanced Neuroendocrine Carcinoma.
  10. Study Assessing RLT Using [177Lu]Lu-PentixaTher for Relapsed/Refractory CXCR4+ Acute Leukemia.
  11. Phase II Clinical Study of LTC004 in Patients With mCRC
  12. A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
  13. Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A)
  14. A Study of MHB039A for Advanced Solid Tumor
  15. Efficacy and Safety Study of Lurbinectedin and Dostarlimab in Cancer Patients: Protocol VHIO21001 - LiDer
  16. Phase II Clinical Study of LTC004 in Patients With Advanced Sarcoma
  17. Study of ACE-86225106 to Treat Patients With Advanced Solid Tumors
  18. Concurrent Chemoradiotherapy Followed by PD-1 Inhibitor in Advanced Cervical Cancer
  19. Linperlisib Combined With Camrelizumab and Pegaspargase in Advanced or Relapsed/Refractory NK/T-cell Lymphoma
  20. Treatment of Relapsed or Refractory B-cell Lymphoma With Chimeric Antigen Receptor (CAR) T-cell Therapy Produced by a New Technology
  21. Manipulation of the Gut Microbiome by a Standardized Preoperative Diet to Prevent Colorectal Cancer Recurrence and Metastasis Following Surgery
  22. PSMA Therapy and Immunotherapy in Kidney Cancer
  23. A Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy of the Combination of BAT8008 With BAT1308 in Patients With Advanced Solid Tumors
  24. A Study of TAK-853 in Adult Participants With Folate Receptor Alpha-Positive Advanced Ovarian Cancer And Other Solid Tumors
  25. IBI3001 in Participants With Unresectable, Locally Advanced or Metastatic Solid Tumors
  26. Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for Chronic Lymphocytic Leukemia (CLL)
  27. A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
  28. JAB-30355 in Patients With Advanced Solid Tumors Harboring TP53 Y220C Mutation
  29. Phase I/II Study of Engineered T Cell Receptor-Modified NK Cells Targeting PRAME in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Myeloid Malignancies
  30. Neoadjuvant Lu-PSMA Radioligand Therapy and Ipilimumab in Men With Very High-risk Prostate Cancer
  31. Vebreltinib Plus PLB1004 in EGFR-mutated, Advanced NSCLC With MET Amplification or MET Overexpression Following EGFR-TKI
  32. A Study of GFH009 in Combination With Zanubrutinib in Subjects With Relapsed or Refractory DLBCL
  33. RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis
  34. A Study to Investigate APL-4098 Alone and/or in Combination With Azacitidine in R/R AML and High-Risk MDS
  35. An Evaluation of BAT 8010 for Injection in Combination With BAT 1006 in Locally Advanced or Metastatic Entities Safety, Tolerability, Pharmacokinetic Profile, and Initial Clinical Efficacy of the Tumor in Patients Multicenter, Open Phase Ib/IIa Clinical Study
  36. A Study of MHB036C for Advanced Solid Tumor
  37. Trial to Assess the Safety and Preliminary Efficacy of GEN1055 on Malignant Solid Tumors as Monotherapy and as Combination Therapy
  38. Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis
  39. PRaG Therapy in Combination With Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC) (NeoPRAG Study)
  40. A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer
  41. A Phase 1/2 Study of 177Lu-NYM032 Injection in mCRPC
  42. A Study of HRS-4642 in Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
  43. A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03)
  44. A Study of 3HP-2827 in Treatment of Unresectable or Metastatic Solid Tumors With FGFR2 Alterations
  45. SHR-8068 Combined With Adbelizumab and BP102 in the Treatment of Advanced Colorectal Cancer
  46. Newly Emerging Immunotherapy for Pancreatic Cancer Treatment
  47. A Phase 1/2 Study of PBI-410 in Advanced Solid Tumors
  48. A Study of Radiprodil on Safety, Tolerability, Pharmacokinetics, and Effect on Seizures and Behavioral Symptoms in Patients With TSC or FCD Type II
  49. To Evaluate the Safety, Efficacy, and Pharmacokinetics of Intravesical Instiliations of Disitamab Vedotin in Patients With High-risk Non-muscular Invasive Bladder Cancer (NMIBC) That Express HER2
  50. A Phase I/II Single-arm Trial of Azenosertib (ZN-c3) Combined With Carboplatin and Pembrolizumab in Patients With Metastatic Triple-negative Breast Cancer (ZAP-IT)
  51. Exploratory Study of Irinotecan Liposomes in Maintenance Therapy of Metastatic Colorectal Cancer
  52. Phase Ib/II Trail of Neoadjuvant of Tislelizumab Combined With Palbociclib in Patients With Platinum-refractory Bladder Urothelial Carcinoma
  53. RC48 Combined With Toripalimab as Neoadjuvant Therapy for Cisplatin Ineligible MIBC Patients
  54. T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
  55. Phase 1:
  1. Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells
  2. Phase 1 Trial of KH801
  3. Weekly Irinotecan Liposomes in Recurrent or Refractory Ewing Sarcoma
  4. Tumor Nutritional Therapy in the First-line Treatment of Stage IV NSCLC
  5. A First-in-Human Study to Learn About How BAY3630942 is Distributed and Processed Inside the Body When Given After BAY3547922 and How Safe it is in People With Liver Cancer
  6. Safety and Efficacy of CD19-BCMA Targeted CAR-T Therapy for Refractory Generalized Myasthenia Gravis
  7. Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma
  8. Ziftomenib in Combination With Chemotherapy for Children With Relapsed/Refractory Acute Leukemia
  9. BM201 in Combination With Radiotherapy in Patients With Advanced Solid Tumors
  10. A Phase 1 Study to Evaluate TGI-6 in Subjects With Locally Advanced/Metastatic Solid Tumors
  12. Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ICP-248 in Mature B-cell Malignancies
  13. Genetically Engineered Cells (EGFRt/19-28z/IL-12 CAR T Cells) for the Treatment of Relapsed or Refractory CD19+ Hematologic Malignancies
  14. A Study With BPI-1178 and Osimertinib in Advanced Non-small Cell Lung Cancer Patients With EGFR Mutations
  15. Dose Escalation and Expansion Study to Evaluate the Safety, PK, PD and Efficacy of ZE46-0134 in Adults With FLT3 Mutated Relapsed or Refractory Acute Myeloid Leukemia
  16. ASTX727 and Nivolumab in Squamous Cell Carcinoma of the Head and Neck
  17. A Study to Learn About How Food and Esomeprazole Affect the Level of BAY2927088 in the Blood When Taken Together in Healthy Participants
  18. A Clinical Trial in Adults With Non-Hodgkin Lymphoma (NHL), With a Particular Emphasis on Cutaneous T Cell Lymphoma (CTCL), Testing the Safety and Activity of a Novel Drug to Inhibit a Protein Called Tumor Necrosis Factor Receptor 2 That Drives Both Lymphoma Growth and Escape of the Immune System
  19. BG1805 Injection in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia in Children
  20. Intraperitoneal FT536 in Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
  21. RNA-Lipid Particle (RNA-LP) Vaccines for Recurrent Adult Glioblastoma (GBM)
  22. Dose Escalation and Expansion Study of TROP2 CAR Engineered IL-15- Transduced Cord Blood-derived NK Cells in Combination With Cetuximab in Patient With Colorectal Cancer (CRC) With Minimal Residual Disease (MRD)
  23. A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of SSGJ-705 Monotherapy in Patients With Advanced Malignant Tumors
  24. A Clinical Study of HMPL-506 in Patients With Hematological Malignancies
  25. Pharmacokinetics, Biodistribution, Radiation Dose and Safety Study of 68Ga-NYM005 in Patients
  26. Iadademstat in Combination With Azacitidine and Venetoclax in Treating Newly Diagnosed Acute Myeloid Leukemia
  27. SNC115 Injections in Patients With Recurrent/Refractory Small Cell Lung Cancer and Lung Large Cell Neuroendocrine Carcinoma
  28. A Study of CHS-1000 in Participants With Advanced or Metastatic Solid Tumors
  29. A Study of RO7617991 in Patients With Locally Advanced or Metastatic MAGE-A4-Positive Solid Tumors
  30. A Study to Find a Suitable Dose of ASP4396 in Adults With Solid Tumors
  31. Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma
  32. Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
  33. Study to Evaluate the Drug-drug Interaction of JMKX001899 in Healthy Subjects
  34. Safety, Pharmacokinetics, and Preliminary Efficacy of BYON4413 in Acute Myeloid Leukemia and Myelodysplastic Neoplasms.
  35. Safety and Immunogenicity of Innocell Autologous Cellular Immunotherapy in Recurrent Epithelial Ovarian Cancer
  36. A Study of Recombinant Oncolytic Virus M1(VRT106) in Patients With Solid Tumors
  37. A Phase I Study of BR115 for Injection Alone in Subjects With Advanced Solid Malignancies
  38. Clinical Evaluation of 177Lu-AB-3PRGD2 in Various Solid Tumors With Integrin Ξ±vΞ²3 Positive Expression
  39. Pharmacokinetics, Biodistribution, Radiation Dose and Safety Study of 68Ga-NYM032 in Patients
  40. Testing the Combination of the Anticancer Drugs Trastuzumab Deruxtecan (DS-8201a) and Azenosertib (ZN-c3) in Patients With Stomach or Other Solid Tumors
  41. The Clinical Study of SHR-7631 for Injection in Patients With Advanced Solid Tumors
  42. Talquetamab in Combination With Iberdomide and Dexamethasone for Relapsed or Refractory Multiple Myeloma
  43. A Study of RAG-01 in Patients With Non-muscle-invasive Bladder Cancer (NMIBC) Who Have Failed Bacillus Calmette GuΓ©rin (BCG) Therapy
  44. A Study Investigating the Change in Metabolism Phenotype in Paediatric, Adolescent & Young Adults With Hodgkin or Non-Hodgkin Lymphoma.
  45. Oncolytic Virus Plus Anti-PD1 and Chemotherapy as Preoperative Therapy for Patients With BRPC/LAPC
  46. IL13RΞ±2 CAR-T for Patients With r/r Glioma
  47. Molecularly Targeted Theranostic Approach for the Detection and Treatment of Metastatic Carcinomas
  48. A Vaccine (Neoantigen-Targeted ppDC) for the Treatment of H3 G34-mutant Diffuse Hemispheric Glioma
  49. PK/PD Study of SHR-2017 Injection in Patients With Bone Metastases
  50. Targeted Radionuclide Therapy in Metastatic Prostate Cancer Using a New PSMA Ligand Radiolabelled With Terbium-161 (161Tb-SibuDAB) - Dose Identification/Escalation Phase Ia/b Study
  51. Allogeneic Gamma-delta T Cells Combined With Targeted Therapy and Immunotherapy in a Phase 1 Clinical Trial for First-line Treatment of Hepatocellular Carcinoma
  52. Alectinib in Combination With Nivolumab in the Treatment of Recurrent or Refractory HCC Patients Guided With Serum RNase1 and Tumor Expression of PD-L1
  53. Engineering Tumor Infiltrating Lymphocytes Injection (GC203 TIL) for the Treatment of Advanced Malignant Solid Tumors
  54. HS-IT101 Injection in the Treatment of Advanced Solid Tumors
  55. UTAA06 Injection for Treatment of Advanced Malignant Solid Tumors
  56. A Study Comparing Pharmacokinetic and Safety of QL2109 and DARZALEX FASPROΒ® in Healthy Adults
  57. A Study of CLN-619 (Anti-MICA/MICB Antibody) in Patients With Relapsed and Refractory Multiple Myeloma
  58. NEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted Radioligand Therapy in Metastatic Neuroendocrine Prostate Cancer.
  59. Study of VG2025 Delivered Intraperitoneally in Patients With Advanced Solid Tumors With Carcinomatosis
  60. Phase 1 Study of GEN2 in Patients With Advanced Solid Tumors
  61. Avidination for RadionuclideTHerapy in Nonpalpable Breast Cancer
  62. Combination of Cardonizumab Injection and TKI Second Line Therapy for Advanced Hepatocellular Cancer
  63. A Phase I Study to Evaluate the Safety,Tolerability, Pharmacokinetics, and Efficacy of YL211 in Patients With Advanced Solid Tumors
  64. Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells for Gastric/Gastroesophageal Junction Adenocarcinoma
  65. A Study to Learn About How Itraconazole and Carbamazepine Affect the Level of BAY2927088 in the Blood When These Drugs Are Taken Together by Healthy Participants
  66. SHR-A1904 Combinations in CLDN18.2-Positive Advanced Solid Tumor
  67. Study of AU409 Capsule in Advanced Hepatocellular Carcinoma Patients Who Failed Standard Treatment
  68. A Study to Test the Benefit of Vitamin B5 in Patients With Melanoma
  69. A Phase 1 Study of AJ1-11095 in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i)
  70. Clinical Evaluation of 177Lu-DansyI-PSMA (LNC1011) in Patients With Metastatic Castration-Resistant Prostate Cancer
  71. A Study of the Safety, Dosing, and Delivery of NEO100 in Patients With Pediatric Brain Tumors
  72. A Clinical Trial of TQB3006 Tablets in Patients With Advanced Malignant Cancer
  73. A Study Evaluating AMG 193 in Combination With Other Therapies in Participants With Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous Methylthioadenosine Phosphorylase (MTAP)-Deletion
  74. A Study of GLB-001 in Patients With Myeloid Malignancies
  75. Safety and Tolerability of LDRT Plus Concurrent Partial SBRT and Tislelizumab in Patients With Bulky Tumors
  76. AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas
  77. A Clinical Study of Anti-CD70 UCAR-T in Relapsed or Refractory Solid Tumors
  78. Phase 1 Study Evaluating Safety and Tolerability of SL-T10, GX-I7, and Pembrolizumab Triple Combination in mCRPC.
  79. Neoantigen Vaccine Plus Anti-PD1 and Chemotherapy as an Adjuvant Therapy for Pancreatic Cancer
  80. Safety, Pharmacokinetics (PK), and Efficacy of ONC 841 in Advanced Solid Tumors
  81. A Study of BL-M05D1 in Patients With Locally Advanced or Metastatic Solid Tumors
  82. A Study to Learn About How BAY2927088 Affects the Level of Midazolam in the Blood When Both Drugs Are Taken Together in Healthy Participants
  83. Phase I Clinical Study of Ξ±-PD-L1/DLL3 CAR-T in Patients With R/R SCLC
  84. TSN084 Treating Patients With Advanced Malignant Tumors
  85. A Phase I Clinical Study of HRS-7058 in Patients With Advanced Malignant Tumour
  86. Irreversible Electroporation & Pembro Immunotherapy in Locally Advanced Pancreatic Cancer
  87. Phase 1 Clinical Trial to Evaluate the Safety and Anti-Tumor Activity of AB-201
  88. A Study of DR-0201 in Subjects With Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
  89. A Phase I Study of [177Lu]Lu-EVS459 in Patients With Ovarian and Lung Cancers
  90. CRTE7A2-01 TCR-T Cells for HPV-16 Positive Advanced Cancers
  91. Molecular Imaging of EpCAM Receptors Using [123I]I-DARPIN-Ec1

Early Phase 1:

  1. KSD-101 Therapy for Standard Treatment Failed EBV-associated NPC: an Exploratory Clinical Trial
  2. Study on the Clinical Application Value of PET Imaging Targeting GPC3 in Hepatocellular Carcinoma
  3. Evaluate Safety, Whole-Body Distribution and Radiation Dosimetry in Metastatic Castration Resistant Prostate Cancer
  4. Clinical Study of Personalized Chemotherapy for Breast Cancer With Low Doses of Cyclophosphamide
  5. CD19-BAFF CAR-T Cells Therapy for Patients With Relapsed / Refractory B-cell ALL and B-cell NHL
  6. Safety and Efficacy of Intravenous IDOV-SAFETM in Patients With Advanced Solid Tumors
  7. Pilot Study of Vinblastine and Tovorafenib in Pediatric Patients With Recurrent/Progressive RAF Altered Low Grade Gliomas
  8. PET Imaging Study of 68Ga-NB381 in Multiple Myeloma
  9. An Clinical Study of NKG2D-CAR-NK Cells for the Treatment of Refractory Recurrent Multiple Myeloma
  10. A Clinical Study on Evaluating Intravenous Administration of IDOV-SAFE
  11. Study of SYS6020 in BCMA-positive Multiple Myeloma
  12. Allogeneic Gamma-delta T Cells Combined With Targeted Therapy and Immunotherapy in a Phase 1 Clinical Trial of Hepatocellular Carcinoma Resistant to PD-1 Monoclonal Antibody
  13. A Trial of Omeprazole and Low Dose Aspirin to Identify Colorectal Biomarkers of Preventive Efficacy
  14. Oral Inulin in Combination With Fruquintinib Plus Sintilimab as Third- or Further-line Treatment in Metastatic Colorectal Cancer
  15. Anti-CD19-CAR-T Cells in Relapsed/Refractory B-cell Tumor Patients.
  16. PBI-MST-01 (NCT04541108) Substudy AZN-05: Intratumoral Microdosing of Rilvegostomig, Volrustomig, and Sabestomig in HNSCC

Phase Not Applicable:

  1. Interventions for the Management of Perineal Cancer Pain
  2. A Randomized, Multicenter Phase II Basket Study of Hypofractionated Radiotherapy/Stereotactic Body Radiotherapy Followed by Immunotherapy-Based Systemic Therapy +/- L. Rhamnosus M9 for the First-Line Treatment of Advanced Digestive System Malignancies.
  3. STRatIfication of Vulvar SCC by HPV and p53 Status to Guide Excision
  4. FIH Clinical Investigation of Graphene Electrodes for Brain Mapping
  5. Fasting Mimicking Diet in Chemotherapy of Gynecologic Malignancies
  6. THRIVE Study: Positive Affect Training for Endocrine Therapy Medication Adherence
  7. Auricular Acupuncture and Hot Flashes During Adjuvant Endocrine Therapy
  8. 99mTc-CNDG SPECT/CT in Brain Tumors
  9. Evaluating a Nonessential Amino Acid Restriction (NEAAR) Medical Food With Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer (LARC)
  10. The Effect of Tennis Ball on Balance and Quality of Life in Cancer Patients With Neuropathy.
  11. Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)
  12. XH001 Combination With Ipilimumab and Chemotherapy for Patients With Resected Pancreatic Cancer
  13. Effect and Safety of Ocoxin Oral Solution on the Quality of Life of Paediatric Patients With Advanced Stage Solid Tumours
  14. Effects of Behavioral Activation on Negative Emotions, Cancer-related Symptoms and Clinical Indicators in Cancer Patients
  15. Feasibility of a Whole-Food, Plant-Based Diet for Patients With Low-Risk Chronic Lymphocytic Leukemia (CLL)
  16. Evaluation of the Venous Thrombotic Biological Profile of Different PCOS Phenotypes: French Cross-sectional Study
  17. Pilot Study of Financial Navigation Program for Improving Financial Toxicity Among Breast Cancer in China
  18. Pretreatment With HCQ Before Radiotherapy and Chemotherapy in Advanced NPC Patients
  19. Evaluate the Effectiveness and Safety of Raman IVD Analyzer in the Molecular Diagnosis of Gliomas During Surgery
  20. Single- vs Two-staged Excisions of Thin Melanoma
  21. Molecular Analysis for Gastro-Esophageal Cancer: Multicenter Discrete Choice Experiment
  22. Clinical Effects of Absorbable and Non-absorbable Suture in Bronchial Sleeve Resection
  23. Exercise in Patients With Advanced Non-small Cell Lung Cancer
  24. Ultra Low Dose CT and Use of Iomeron 400 in PCD-CT
  25. Impact of Different Hemostasis Methods on Ovarian Function and Fertility During Laparoscopic Ovarian Cystectomy of Benign Ovarian Cyst
  26. New Urethral Reconstruction in Robot-assisted Laparoscopic Radical Resection
  27. ASk Questions in GYnecologic Oncology (ASQ-GYO)
  28. A Conversational Agent (Cecebot) to Improve Insomnia in Stage I-III Breast Cancer Survivors
  29. Personalized Rendering of Motor System Functional Plasticity Potential to Improve Glioma Resection and Quality of Life
  30. Does Continuous Vital Sign Monitoring Increase Investigations and Interventions in Complication-free Patients?
  31. Impact on Quality of Life and Health of the CONTINUUM+ CONNECT Remote Monitoring Solution
  32. A Study on the Efficacy and Safety of Oral All-trans Retinoic Acid Combined With Toripalimab in TNBC.
  33. EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope
  34. BAI-BACE for Advanced Lung Squamous Cell Carcinoma
  35. Supraclavicular Lymph Node Dissection for Ipsilateral Supraclavicular Lymph Node Metastatic Breast Cancer
  36. Arthroscopic Versus Open Excision of Dorsal Wrist Ganglion
  37. Effect of Aloe Vera Gel and Manuka Honey on Radiation Induced Oral Mucositis
  38. Using Behavioural and Cultural Insights to Increase Colorectal Cancer Home-testing in Croatia
  39. Increasing Equity in Lung Cancer Screening
  40. CD19-targeted CAR T Cell Autotransfusion for the Treatment of Recurrent/Refractory B-cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma in Children With CD19+
  41. Comparison of MRI AI-cTB Versus Routine cTB in Prostate Cancer Diagnosis: a Prospective Randomized Controlled Trial
  42. The Effect of Foot Massage With Roles on Cancer Patients
  43. Expanding Access to Care Through Telemedical Support for Vital Sign Monitoring in High-risk Patients With Cancer
  44. The Effects of Immunonutrition Therapy on Locally Advanced Cervical Cancer Patients
  45. App-based Recording and Optimization of the Nutritional Status in Patients With Head and Neck Tumors During and After Radio(Chemo)Therapy
  46. The Effect of Appropriate Family Companionship on the Physical and Mental Health of Patients With Advanced Breast Cancer
  47. A Novel Smart Speculum Versus a Standard Speculum for Easy Visualisation of the Cervix and Performing Remote Cervical Cancer Screening
  48. Investigating the Role of Energy Balance Modification on Health Responses in Chronic Lymphocytic Leukaemia
  49. Varian ProBeam360Β° Proton Therapy System China Clinical Trial (Wuhan)
  50. EPIBONE Study: a Prospective Study on Feasibility, Safety and Accuracy
  51. A Study to Assess the Ability of Stereotactic Radiotherapy to Restore the Efficacy of Immunotherapy in Patients With Metastatic Cancer.
  52. Effect of Stellate Ganglion Block on Postoperative Nausea and Vomiting
  53. Stellate Ganglion Block Combined With Dexmedetomidine or Subanesthetic Ketamine Infusion for Treatment of Neurostorm.
  54. Evaluate the Efficacy of Adding Intraluminal Brachytherapy After CCRT for Local-regional Thoracic Esophageal Cancer.
  55. Feasibility and Acceptability of Internet-based Parent-child Interaction Therapy (I-PCIT) in Pediatric Cancer
  56. Evaluation of the Effect of Photobiomodulation on Sexual Quality of Life in Women With Breast Cancer
  57. Efficacy and Toxicity of SCART
  58. Return to School Adaptation Programme for Children With Cancer
  59. A SMART Design to Optimize the Delivery of TEMPO for Men With Prostate Cancer and Their Caregivers
  60. Improving Colonoscopy Surveillance for Patients With High Risk Colon Polyps
  61. Accuracy of 18F-rhPSMA-7.3 PET/ MRI for Prediction of Lymph Node Metastasis in Localized High-Risk Prostate Cancer
  62. Pre-operative Immuno-Nutrition in Radical Cystectomy
  63. Lactobacillus Rhamnosus GG Alleviates Oral Mucositis in Patients Undergoing Radiotherapy
  64. EUS-Gallbladder vs CDS as First Line in MBDO- Palliative (CARPEGIEM Trial)
  65. Clinical Trial of CD19 and CD22 CAR Sequential Therapy Versus Single CD19 CAR Bridging to HSCT for r/r B-ALL Patients
  66. Investigation of the Effect of Lipikar Baume AP+M
  67. Conversational Agents to Improve HPV Vaccine Acceptance in Primary Care (ECA-HPV) Clinical Trial
  68. Electroacupuncture in Symptom Management After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
  69. Breast Cancer and Breast Self-examination Education
  70. Exploration of the Value of PSMA PET/CT in Dynamic Monitoring of the Efficacy of Novel Endocrine Therapy in Patients With Metastatic Hormone Sensitive Prostate Cancer
  71. Longitudinal Study of Local Ablative Therapy in Oligometastatic Disease
  72. Laparoscopic Right Hemicolectomy With Transrectal Specimen Extraction for Colon Cancer
  73. Clinical Applications of Integrated PET/MR and PET/CT in the Diagnosis and Treatment of Prostate Cancer.
  74. Evaluating a Physical Activity Index for Assessment and Counseling for Breast and Colon Cancer Survivors
  75. Infective Complications in TP Biopsy Without Antibiotic Prophylaxis
  76. Chidamide, Venetoclax, and Azacitidine for Newly Diagnosed Acute Myeloid Leukemia
  77. A Prospective Clinical Study on the Safety and Efficacy of Radiofrequency Ablation for the Treatment of Patients With Desmoid Tumors
  78. Mid-point Transverse Process to Pleura Block Versus Thoracic Paravertebral Block in Posterolateral Thoracotomy
  79. Sustaining Physical Activity After Cancer Exercise Sessions
  80. Eye Movement Desensitization and Reprocessing Group Treatment for Caregivers of Pediatric Brain Tumor Patients
  81. Liver Volume Variation Effect on SBRT Planning and Delivery for Upper Abdominal Malignancies
  82. The Effect of Foot Massage and Bed Bath on Individuals With Cancer
  83. Donor-Derived EBV-Specific T Cells for Life Threatening EBV-lymphoma (OLIP-EBV-TCL-01-HMR01)
  84. Effects of Topical Sesame Oil in the Prevention of Peripheral Venous Catheter Phlebitis: Clinical Trial.
  85. Evaluating the Role of ChatGPT in Educating Patients With Early-stage Hepatocellular Carcinoma
  86. The Effect of Hand Massage Applied to Palliative Care Oncology Patients
  87. Exploring the Potential of ctDNA-MRD for Recurrence Surveillance and Prognostic Evaluation in High-risk Endometrial Cancer
  88. Feasibility Study of Multidimensional Rehabilitation in the Metaverse
  89. Peritoneum and Anterior Rectus Sheath Suturing and Ileostomy
  90. 68Ga-FAPI-46 PET/CT for Predicting Histological Response in Triple-negative Breast Cancer (FAP-IT)
  91. Program of Health Behaviour Against to Cancer (PHeBAC)
  92. Efficacy and Safety of DEB-BACE Combined With Serplulimab in First-line Treatment of SCLC
  93. Lymphocyte Enhancement in Gastroenteric Oncology
  94. Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors
  95. Improving Endometrial Cancer Assessment by Combining Genomic Profiling and Surgical Assessment
  96. Tislelizumab in Combination With Chemotherapy as a Neoadjuvant Treatment for Advanced Endometrial Cancer
  97. Efficacy and Safety of MTBF Conditioning Regimen for Salvageable Allo-HSCT in the Treatment of R/R AML
  98. Co-Design and Pilot Testing of Peer-led Community Outreach to Improve Equity, Veteran-Centeredness and Uptake of Lung Cancer Screening
  99. Building Empowerment and Coping Outcomes for caNcer Patients, Survivors and Their Caregivers
  100. Fasting During Neoadjuvant Chemotherapy in Patient With Epithelial Ovarian Cancer
  101. Using the EHR to Advance Genomic Medicine Across a Diverse Health System
  102. The FEMA Study: Feasibility of Exercise in Patients With Metastatic Breast Cancer and Adiposity
  103. Biological and Clinical Efficacy of Shingrix in Patients With CLL
  104. Music Therapy for Cancer Patients(Meraki_PC)
  105. Lifei Xiaoji Wan Treatment's of Early-stage NSCLC and Its Impact on the Tumor Microenvironment
  106. Visual Telerehabilitation in Children, Adolescents and Young Adults With Hemianopsia Consecutive to a Brain Tumour
  107. Sub-lobectomy for IDH Wild-type and TERT Promoter Mutant Glioblastoma
  108. A Study of Telemonitoring in Cancer Patients
  109. Medico-economic Evaluation of Robot-assisted Laparoscopy Compared With Conventional Laparoscopy in Hysterectomy for Endometrial Cancer.
  110. A Tele-exercise Program for Breast Cancer Survivors
  112. HPV Self-sampling for Women Who do Not Attend Cervical Cancer Screening Programme
  113. Effects of Using a Storybook, to Explain Leukemia to Children Versus the Standard Child Life Intervention, on Parental Stress.
  114. Personalization of Breast Radiotherapy According to Loco-regional Recurrence Risk and Toxicity Probability
  115. Comparison of the Effectiveness of the Simple Puncture Compared to the Incision of an Abscess on the piLOnidal Sinus
  116. Transhiatal Tunnel Valvuloplasty for Reconstruction Following the Laparoscopic Proximal Gastrectomy
  117. Using an End-of-life Conversation Game to Engage Patients With Cancer in Advance Care Planning: Phase 2
  118. TFL vs MOSES Holmium Laser in the En-bloc Resection of Bladder Tumors
  119. Reiki Therapy to Improve Key Symptoms in Integrative Oncology Clinic (REIKI)
  120. Previvors Recharge: A Resilience Program for Cancer Previvors
  121. Ketogenic Dietary Intervention to Improve Response to Immunotherapy in Patients With Metastatic Melanoma and Metastatic Kidney Cancer
  122. A Patient Navigation Program for Addressing Disparities in Breast Cancer Care
  123. Prehab for Lung and Esophageal Cancer
  124. Efficacy of Intraoperative Use of 20% Albumin Combined With Ringer Lactate Versus Ringer Lactate During Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy
  125. Health Benefits of Writing Therapy Among Asian American Cancer Survivors
  126. Early Detection of Complications During Immunotherapy for Haematological Malignancy
  127. Comparison of Outcomes of Multiple Platforms for Assisted Robotic - Gastrectomy
  128. Is Trogocytosis a Predictive Marker of CAR-T Cell Response in Diffuse Large B-cell Lymphoma?
  129. Short-term and Long-term Outcomes of Colorectal Cancer Treated With Natural Orifice Specimen Extraction Surgery : a National Registry-based Study
  130. The Man Van Project
  131. NT-proBNP to Assess Trastuzumab-induced Cardiotoxicity
  132. A Smart Self-Management Support Programme (3S) to Improve Quality of Life in Lung Cancer Patients
  133. Irinotecan Liposome Combined With Oxaliplatin and Tegafur as Adjuvant Therapy for Pancreatic Cancer
  134. Role of Methylation Test Triage in HPV Positive Women
  135. Preoperative Accelerated Partial Breast Irradiation in Patients With Locally Recurrent or Second Primary Breast Cancer
  136. Pancreatic Cancer and Synchronous Liver Metastases Resection Following Neoadjuvant FOLFIRINOX
  137. Investigator Grant (IG) 2022 27746
  138. A Web-based Program to Help Caregivers of Lung Patients Learn About Available Supportive Care Resources
  139. Thrombin Generation Parameters and Bleeding in Patients Treated With Anticoagulants for Cancer Associated Thrombosis
  140. Electrochemotherapy Induces Changes in the Tumor Microenvironment of Cutaneous and Subcutaneous Metastases in Patients With Cutaneous Melanoma
  141. Mobile Health App to Promote Participation of Black Women in Breast Cancer Clinical Trials
  142. Comparison of pCLE and EB in Gastric Lesion Diagnosis
  143. Totally Robotic Versus Surgeon-Assisted Robotic Lung Resection For Early-Stage NSCLC
  144. Enhancing Lung Cancer Screening Through Human-Centered Intervention
  145. Simultaneous Care in Recurrent and/or Metastatic Head and Neck Cancer: the SupCare Study
  146. Development and Initial Application of a Combined Exercise and Psychological Intervention Program for Patients After Esophagectomy
  147. A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning
  148. Fecal Microbiota Transplantation (FMT) in Patients With Advanced Gastric Cancer
  149. CIK Cell Therapy for Relapsed or Refractory Acute B-Lymphoblastic Leukemia: Prognostic Impact on Patients With Early CAR-T Cell Dysfunction
  150. Therapeutic Play on Pain Tolerance and Emotion Regulation in Children
  151. Molecular Assessment for Gastro-Esophageal Cancer
  152. Implementation of Liquid Biopsies During Routine Clinical Care in Patients With Advanced Malignancies (LIQPLAT)
  153. Whole Body Metabolism in Children Before and After Treatment of CNS Tumor
  154. Esophageal Self-expandable Metal Stent for Malignant Strictures: a Safety and Efficacy Study
  155. Permanence of Indocyanine Green in Axillary Lymph Nodes 3 Weeks After Subdermal Injection in Patients With Breast Cancer and Metastatic Lymph Nodes
  156. EUS-guided CDS vs ERCP as First Line in Malignant Distal Obstruction in Borderline Disease (CARPEDIEM-2 Trial)
  157. The Role of Mesenchymal Stem Cell and Exosome in Treating Pilonidal Sinus Disease in Children
  158. Prehabilitation Exercise Program in Breast Cancer: Effects on Quality of Life and Tumor Microenvironment (PEP_BC)
  159. Emotion and Symptom-Focused Engagement (EASE) for Caregivers
  160. BCAA in Patients Undergoing Gastric Cancer Surgery
  161. Financial Incentives and Motivational Intervention to Improve Gastric Cancer Screening in China
  162. Prospective Multicenter Cohort Study to Validate Four Groups of Biomarkers for Assessing Lung Cancer Risk Among Patients With Atheromatous Cardiovascular Disease in a Screening Pathway
  163. Functional and Phenotypic Characterization of Monocytes in Myeloproliferative Syndromes
  164. The Effect of Web-Based Breast Self-Examination Education
  165. Efficacy of TEAS on Postoperative Pain and Recovery in Patients Undergoing Hepatectomy
  166. Providing Web-based Training to Parents Of Children With Leukemia
  167. Blood and Tissue Extraction for Immunological Examinations During Neoadjuvant Therapy of Soft Tissue Sarcomas
  168. Comparison of MRI Artificial Intelligence-guided cTB Versus Routine cTB in Prostate Cancer Diagnosis
  169. Hepatocellular Carcinoma Liver Organoids
  170. Dermatoscopy Guided Resection for Skin Cancer
  171. PD-L1 Specific [68Ga]-Nb-1 Nanobody Probe for PET Imaging in Solid Tumors
  172. The Outcomes of Ultrasound-guided Thermal Ablation for Benign Thyroid Nodules
  173. Fasting Mimicking Diet With Chemotherapy in Patients With Leukemia
  174. InvestigatioN of a Smart Probe for Lung lEsion Characterization Using Impedance Technology
  175. Transgender and Gender Diverse Individuals Screening for Breast Cancer
  176. Marrow Cellutionβ„Ά vs. Traditional BMA Harvest Project
  177. EUS-guided Choledochoduodenostomy vs ERCP as First Line in Malignant Distal Obstruction in Resectable Disease (CARPEDIEM-1 Trial)
  178. Breast Cancer Screening in Ghana
  179. Improving Quality of Life in Older Patients With Frailty and Hematological Cancer Through Geriatric Assessment
  180. A Randomized Controlled Trial of the Safety and Efficacy of Robotic Telesurgery Versus Laparoscopic Surgery
  181. a SIngle Center Study of Post-operative STEReotactic RAdiotherapY for Endometrial Cancer
  182. Narrative Medicine for Improving Well-Being in Patients With Gastrointestinal Cancers
  183. Skin Cancer and Hyperthermia and Radiotherapy
  184. Examining Arts as Therapy in Children With Cancer, CREATe Trial


The above Clinical Trial information has been retrieved from